Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Adma Biologics
(NQ:
ADMA
)
6.200
+0.160 (+2.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,983,796
Open
6.030
Bid (Size)
6.050 (2)
Ask (Size)
6.190 (3)
Prev. Close
6.040
Today's Range
6.010 - 6.210
52wk Range
3.060 - 6.750
Shares Outstanding
196,357,149
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
A Closer Look at 6 Analyst Recommendations For ADMA Biologics
March 26, 2024
Via
Benzinga
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
March 11, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Performance
YTD
+36.26%
+36.26%
1 Month
+0.16%
+0.16%
3 Month
+23.51%
+23.51%
6 Month
+96.83%
+96.83%
1 Year
+79.19%
+79.19%
More News
Read More
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
March 05, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Forecasting The Future: 4 Analyst Projections For ADMA Biologics
February 29, 2024
Via
Benzinga
Recap: ADMA Biologics Q4 Earnings
February 28, 2024
Via
Benzinga
Earnings Preview For ADMA Biologics
February 27, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For ADMA Biologics
January 22, 2024
Via
Benzinga
Earnings Preview: ADMA Biologics
November 07, 2023
Via
Benzinga
Preview: ADMA Biologics's Earnings
August 08, 2023
Via
Benzinga
ADMA Biologics Announces CFO Transition
February 28, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 28, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 21, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
February 21, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
January 08, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
December 18, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
December 12, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Why Adma Biologics Stock Crushed the Market on Friday
November 17, 2023
Via
The Motley Fool
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
November 16, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Why Adma Biologics Was Trouncing the Market Today
November 09, 2023
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 08, 2023
Via
Benzinga
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
November 08, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
November 01, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Why Shares of ADMA Biologics Are Climbing Thursday
August 10, 2023
Via
The Motley Fool
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
August 09, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
August 02, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.